Week26, 2024
1. Influenza activity is low nationwide, with 1.0% of respiratory specimens testing positive for influenza.
2. Clinical labs reported 85.5% of positive specimens as Influenza A and 14.5% as Influenza B.
3. Public health labs identified 89.0% Influenza A and 11.0% Influenza B specimens, with A(H1N1)pdm09 and A(H3N2) subtypes co-circulating.
4. Three pediatric influenza-associated deaths were reported this week, bringing the total this season to 184.
5. Outpatient respiratory illness visits accounted for 1.4% of total visits, below the national baseline, with minimal activity across all jurisdictions.
6. Weekly hospitalization rate is low at 0.1 per 100,000, with a cumulative seasonal count of 25,196 hospitalizations.
7. Deaths attributed to influenza slightly decreased, representing 0.02% of total deaths reported this week.
8. A novel A(H5N1) virus case was detected in Colorado, emphasizing risks from avian influenza outbreaks.
9. Antiviral susceptibility testing revealed minimal resistance to common medications, with sporadic mutations identified.
10. CDC expects low influenza activity in the near term but continuous monitoring is crucial with co-circulating respiratory viruses, including COVID-19 and RSV.